The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

This study has been terminated.
(Efficacy signals were insufficiently strong to justify recruitment of additional patients.)
Sponsor:
Information provided by (Responsible Party):
Janssen Pharmaceutica N.V., Belgium
ClinicalTrials.gov Identifier:
NCT01137799
First received: June 3, 2010
Last updated: November 7, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2011
  Estimated Primary Completion Date: No date given
No publications provided by Janssen Pharmaceutica N.V., Belgium

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):